![Michael Leek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Leek
Amministratore Delegato presso TCB Newco Ltd.
Profilo
Michael Leek is the founder and Chief Executive Officer of TC Biopharm Ltd., a position he has held since 2014.
He was also the founder of TC Biopharm (Holdings) Plc, where he served as the Chief Technology Officer in 2023.
Dr. Leek is also the founder of TCB Newco Ltd.
In his former job, he worked at Intercytex Ltd.
from 2000 to 2006, holding the position of Vice President-Operations.
Dr. Leek obtained a doctorate degree from the University of Leeds.
Posizioni attive di Michael Leek
Società | Posizione | Inizio |
---|---|---|
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Amministratore Delegato | - |
Precedenti posizioni note di Michael Leek
Società | Posizione | Fine |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Amministratore Delegato | 01/06/2021 |
Intercytex Ltd.
![]() Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Direttore operativo | 03/02/2006 |
TC Biopharm Ltd.
![]() TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Amministratore Delegato | - |
Formazione di Michael Leek
University of Leeds | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Aziende private | 3 |
---|---|
Intercytex Ltd.
![]() Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
![]() TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Borsa valori
- Insiders
- Michael Leek